Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
252.60    -1.40 (-0.55%)
Bid:
252.00
Ask:
252.20
Spread: 0.20 (0.079%)
Market Cap: £636.52m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Directorate Change

5 Apr 2023 07:00

RNS Number : 3914V
Genuit Group PLC
05 April 2023
 

5 April 2023

Genuit Group plc

Directorate changes

Genuit Group plc ("Genuit", the "Company" or the "Group"), a leading provider of sustainable water and climate management solutions for the built environment, today announces that Matt Pullen will step down from the Board and as Chief Operating Officer on 28 April 2023. He will remain an employee of the Company and available to the Board in an advisory capacity until 30 June 2023 to ensure an orderly handover of responsibilities, which will be distributed amongst the senior leadership team. The Board does not intend to appoint a successor.

The Company also announces that Martin Gisbourne, Group Strategy and Marketing Director, will assume the newly expanded role of Chief Strategy and Sustainability Officer and will lead the Company's sustainability journey, in addition to his current focus on our acquisitions and partnership activity.

Kevin Boyd, Chairman, commented: "On behalf of the Board I'd like to thank Matt for the contribution he has made to the Group over the last 18 months, in strengthening our commercial processes and more recently in relation to our refreshed strategy and development of the senior leadership team structure and capability. We wish Matt well for the future."

Matt Pullen, Chief Operating Officer, commented: "It has been a privilege to help lead the business through a significant period of transformation. Genuit has strong foundations and is well placed to achieve the growth ambitions set out in our strategy. I would like to thank the Board, the executive management team and all of my colleagues and wish them every success."

Joe Vorih, Chief Executive Officer, commented: "I would like to personally thank Matt for his hard work and leadership as we made significant improvements over the past year, and for helping to position the Group for continued success as he moves on. We wish him well in his future endeavours.

I would also like to congratulate Martin on his expanded role. Sustainability sits at the heart of our Group strategy and this appointment will help us to continue to progress against our objectives."

Enquiries:

 Genuit Group:

 Joe Vorih, Chief Executive Officer

 Paul James, Chief Financial Officer

+44 (0) 1138 315380

 Brunswick:

Dan Roberts

+44 (0) 20 7404 5959

 

Notes to Editors:

Genuit Group plc ("Genuit", the "Company" or the "Group"), a leading provider of sustainable water, climate and ventilation products for the built environment, is the largest manufacturer in the UK, and among the ten largest manufacturers in Europe, of piping systems for the residential, commercial, civils and infrastructure sectors by revenue. It is also a leading designer and manufacturer of energy efficient solutions in water-based heating systems in the UK.

The Group operates from thirty facilities in total and manufactures the UK's widest range of solutions for heating, plumbing, drainage and ventilation. The Group primarily targets the UK and European building and construction markets with a presence in Italy and the Netherlands and sells to specific niches in the rest of the world.

Genuit Group plc changed its name from Polypipe Group plc on 6 April 2021. The Group was established in 1980 and has been listed on the premium segment of the London Stock Exchange since 2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFFASTISIIV
Date   Source Headline
4th Jun 20263:05 pmRNSHolding(s) in Company
2nd Jun 20261:15 pmRNSDirector/PDMR Shareholding
29th May 20262:39 pmRNSTotal Voting Rights
29th May 20262:23 pmRNSHolding(s) in Company
29th May 20261:59 pmRNSDirector/PDMR Shareholding
28th May 20262:24 pmRNSHolding(s) in Company
27th May 202610:07 amRNSDirector/PDMR Shareholding
26th May 20263:49 pmRNSHolding(s) in Company
22nd May 20263:01 pmRNSResult of AGM
22nd May 20267:00 amRNSTrading Update
5th May 20269:00 amRNSDirector/PDMR Shareholding
1st May 20264:12 pmRNSDirector/PDMR Shareholding
30th Apr 20264:26 pmRNSAdmission to Trading
30th Apr 20264:17 pmRNSTotal Voting Rights
30th Apr 20264:06 pmRNSDirector/PDMR Shareholding
27th Apr 20264:20 pmRNSHolding(s) in Company
14th Apr 20264:32 pmRNSDirector/PDMR Shareholding
14th Apr 202610:11 amRNSNotice of AGM
10th Apr 20261:34 pmRNSBlock Listing Application
7th Apr 20269:58 amRNSHolding(s) in Company
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20266:01 pmRNSTotal Voting Rights
23rd Mar 20263:25 pmRNSHolding(s) in Company
20th Mar 20261:43 pmRNSDirector/PDMR Shareholding
13th Mar 20269:41 amRNSHolding(s) in Company
13th Mar 20269:41 amRNSHolding(s) in Company
11th Mar 20262:12 pmRNSFull-Year 2025 Results Investor Q&A
10th Mar 20267:00 amRNSFinal Results
6th Mar 202611:35 amRNSHolding(s) in Company
5th Mar 20262:46 pmRNSHolding(s) in Company
5th Mar 20262:41 pmRNSHolding(s) in Company
4th Mar 20262:40 pmRNSHolding(s) in Company
3rd Mar 20263:51 pmRNSHolding(s) in Company
2nd Mar 20265:25 pmRNSHolding(s) in Company
27th Feb 20263:18 pmRNSTotal Voting Rights
30th Jan 20266:00 pmRNSTotal Voting Rights
29th Jan 202610:17 amRNSHolding(s) in Company
29th Jan 202610:15 amRNSHolding(s) in Company
29th Jan 202610:06 amRNSHolding(s) in Company
12th Jan 20265:41 pmRNSHolding(s) in Company
31st Dec 202510:00 amRNSTotal Voting Rights
31st Dec 202510:00 amRNSTotal Voting Rights
23rd Dec 20259:08 amRNSHolding(s) in Company
23rd Dec 20259:08 amRNSHolding(s) in Company
23rd Dec 20259:06 amRNSHolding(s) in Company
23rd Dec 20259:06 amRNSHolding(s) in Company
16th Dec 20252:03 pmRNSHolding(s) in Company
16th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20253:41 pmRNSDirector/PDMR Shareholding
10th Dec 20254:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.